T. Rowe Price Associates’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-95,833
Closed -$2.63M 3057
2022
Q3
$2.63M Buy
95,833
+20,848
+28% +$517K ﹤0.01% 1349
2022
Q2
$1.73M Sell
74,985
-6,613
-8% -$154K ﹤0.01% 1665
2022
Q1
$1.78M Buy
81,598
+29,432
+56% +$611K ﹤0.01% 1733
2021
Q4
$1.11M Sell
52,166
-23,899
-31% -$501K ﹤0.01% 1977
2021
Q3
$1.59M Sell
76,065
-1,511
-2% -$33K ﹤0.01% 1831
2021
Q2
$1.79M Sell
77,576
-4,189
-5% -$96.4K ﹤0.01% 1794
2021
Q1
$1.81M Buy
81,765
+31,602
+63% +$732K ﹤0.01% 1768
2020
Q4
$936K Buy
50,163
+7,049
+16% +$116K ﹤0.01% 1975
2020
Q3
$626K Buy
43,114
+3,532
+9% +$44.9K ﹤0.01% 2000
2020
Q2
$443K Buy
39,582
+28,734
+265% +$323K ﹤0.01% 2095
2020
Q1
$108K Buy
+10,848
New +$152K ﹤0.01% 2406

Other funds holding CHNG

T. Rowe Price Associates's CHNG Position: Q4 2022 in Review

T. Rowe Price Associates sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 95,833 shares — an estimated $2.63M sold.

T. Rowe Price Associates first reported a position in CHNG in Q1 2020 and held it in 11 quarters. The position peaked at $2.63M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • T. Rowe Price Associates reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 95,833 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $2.63M.
  • T. Rowe Price Associates first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Change Healthcare Inc. Common Stock position peaked at $2.63M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.